Abstract Number: 1235 • 2013 ACR/ARHP Annual Meeting
Predictors Of Fracture In Patients With Osteopenia: Data From An Observational Cohort
Background/Purpose: The risk factors for osteoporotic fragility fractures are well documented in the literature and although they are associated with a diagnosis of established osteoporosis…Abstract Number: 1236 • 2013 ACR/ARHP Annual Meeting
Outcomes and Costs Of Sacral Insufficiency Fractures
Background/Purpose: Sacral insufficiency fracture (SIF) is a poorly recognised cause of lower back pain in the elderly with significant potential morbidity. Diagnosis is often slow…Abstract Number: 1237 • 2013 ACR/ARHP Annual Meeting
Denosumab Leads To Significantly Greater Increases In Bone Mineral Density Than Ibandronate and Risedronate In Postmenopausal Women At High Risk For Fracture Who Were Previously Treated With An Oral Bisphosphonate
Denosumab Leads to Significantly Greater Increases in Bone Mineral Density Than Ibandronate and Risedronate in Postmenopausal Women at High Risk for Fracture Who Were Previously…Abstract Number: 1238 • 2013 ACR/ARHP Annual Meeting
Persistence At 12 Months With Denosumab (Prolia®) In Postmenopausal Women With Osteoporosis: Interim Results From a Prospective Observational Study
Background/Purpose: Persistence with osteoporosis therapy is important for optimal reduction of fracture risk. Persistence with denosumab was >90% in a randomized clinical trial in women…Abstract Number: 1239 • 2013 ACR/ARHP Annual Meeting
The Effects Of Hyperparathyroidism On Body Mass Index and Bone Mineral Density- An Observational Case-Control Study
Background/Purpose: Hyperparathyroidism is associated with reduced bone mineral density (BMD) and increased fracture risk. A previous study from this group has shown that bone loss…Abstract Number: 1240 • 2013 ACR/ARHP Annual Meeting
Study On The Relationship Between The Preoperative Stay and Morbimortality In Patients With Hip Fracture
Background/Purpose: Introduction: The preoperative stay (PS) in patients with hip fracture has been classically associated with the resultant morbimortality of the process. As a consequence,…Abstract Number: 1241 • 2013 ACR/ARHP Annual Meeting
A Low Serum 25(OH) Vitamin D Level As a Risk Factor For Incidence and Severity Of Vertebral Fracture In Glucocorticoid-Induced Osteoporosis In Japan
Background/Purpose: Although levels of serum 25(OH) vitamin D (25(OH)D) have been discussed for preventing osteoporotic fractures in primary osteoporosis, an importance of the levels has…Abstract Number: 1242 • 2013 ACR/ARHP Annual Meeting
A Prospective Randomized Open Label Trial To Evaluate The Effect Of Food On Vitamin D Absorption
Background/Purpose: Vitamin D deficiency is commonplace throughout the world and is associated with a number of health related consequences. Being a fat-soluble vitamin, speculation has…Abstract Number: 1243 • 2013 ACR/ARHP Annual Meeting
Osteoporosis Medication Adherence: Reasons For Stopping and Not Starting
Background/Purpose: Medication adherence with prescription osteoporosis medications is poor, with approximately half remaining adherent in the first year of treatment. Moreover, approximately one-third who are…Abstract Number: 1245 • 2013 ACR/ARHP Annual Meeting
The Differential Effect Of Smoking On Bone Mineral Density At The Lumbar Spine and Neck Of Femur In Each Gender: An Observational Study
Background/Purpose: Current smoking is a known risk factor for loss of bone mineral density (BMD), and is part of the FRAX ™ 10-year fracture risk…Abstract Number: 1246 • 2013 ACR/ARHP Annual Meeting
Efficacy Of a 6-Month Treatment With Strontium Ranelate 2g/Day In The Improvement Of Long Bone Fractures With Delayed-Union Or Non-Union
Background/Purpose: To assess the efficacy of strontium ranelate 2g/day in the improvement of healing of peripheral fractures with delayed union or aseptic non-union. Methods: International,…Abstract Number: 1247 • 2013 ACR/ARHP Annual Meeting
Association Between Bisphosphonate Switching Behavior and Cost Outcomes In Postmenopausal United States Veterans
Background/Purpose: Many bisphosphonate-treated patients discontinue therapy within the first year. Some later restart the same or a different bisphosphonate. The implications of this on total…Abstract Number: 1248 • 2013 ACR/ARHP Annual Meeting
Prevalence Of Vitamin D Inadequacy In European Postmenopausal Women Aged Over 80 Years
Background/Purpose: Inadequate vitamin D level is associated with secondary hyperparathyroidism and increased bone turnover and bone loss, which in turn increases fracture risk. The objective…Abstract Number: 1249 • 2013 ACR/ARHP Annual Meeting
Contrasting Pathophysiology and Behavioural Responses Associated With Osteoarthritis and An Inflammatory Arthropathy
Background/Purpose: Osteoarthritis (OA) affects more than 15% of the population, and is the major cause of disability in people over 60. There are no therapies…Abstract Number: 1250 • 2013 ACR/ARHP Annual Meeting
Serological Markers Of Structural Integrity and Inflammation Is Associated With Pain In Osteoarthritis
Background/Purpose: Pain is associated with diagnosed osteoarthritis (OA), but little clinically association is found between joint integrity and the pain the individual patient experience. Peripheral…
ACR Meeting Abstracts